Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer.

E Koga-Yamakawa; Simon Dovedi

Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer.

E Koga-Yamakawa, Simon Dovedi

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	International Journal of Cancer
Publication status	Published - 26 Jun 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{98fe029b1adb458ea1baaa0ec4899a71,

title = "Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer.",

author = "E Koga-Yamakawa and Simon Dovedi",

year = "2012",

month = jun,

day = "26",

language = "English",

journal = "International Journal of Cancer",

issn = "1097-0215",

publisher = "John Wiley & Sons Ltd",

}